IMMUNOGENICITY PRIMING RADIATION THERAPY Trademark

Trademark Overview


On Thursday, March 24, 2022, a trademark application was filed for IMMUNOGENICITY PRIMING RADIATION THERAPY with the United States Patent and Trademark Office. The USPTO has given the IMMUNOGENICITY PRIMING RADIATION THERAPY trademark a serial number of 97327958. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Friday, February 9, 2024. This trademark is owned by ImmunityBio, Inc.. The IMMUNOGENICITY PRIMING RADIATION THERAPY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Cells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products comprising cells; products comprising cell-derived preparations; products comprising biologics; kits comprised of cells, other reagents and instructions; kits comprised of cell-derived preparations, other reagents and instructions for the use thereof; kits comprised of biologics, other reagents and instructions for the use thereof; all of the foregoing for clinical, medical, veterinary and therapeutic use in combination with radiation therapy in the treatment and/or prevention of cancer and infectious diseases

Medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of cells and cell-derived preparations; medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of preparations comprising biologics; providing medical information in the fields of cancer and infectious diseases

Research in the field of cancer and infectious diseases; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto for use in combination with radiation therapy
immunogenicity priming radiation therapy

General Information


Serial Number97327958
Word MarkIMMUNOGENICITY PRIMING RADIATION THERAPY
Filing DateThursday, March 24, 2022
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateFriday, February 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products comprising cells; products comprising cell-derived preparations; products comprising biologics; kits comprised of cells, other reagents and instructions; kits comprised of cell-derived preparations, other reagents and instructions for the use thereof; kits comprised of biologics, other reagents and instructions for the use thereof; all of the foregoing for clinical, medical, veterinary and therapeutic use in combination with radiation therapy in the treatment and/or prevention of cancer and infectious diseases
Goods and ServicesMedical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of cells and cell-derived preparations; medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of preparations comprising biologics; providing medical information in the fields of cancer and infectious diseases
Goods and ServicesResearch in the field of cancer and infectious diseases; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto for use in combination with radiation therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 29, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, February 9, 2024ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE
Friday, February 9, 2024ABANDONMENT - INCOMPLETE RESPONSE
Tuesday, August 29, 2023NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Tuesday, August 29, 2023ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Tuesday, August 29, 2023ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Tuesday, August 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 1, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 31, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, July 31, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, May 12, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 12, 2023FINAL REFUSAL E-MAILED
Friday, May 12, 2023FINAL REFUSAL WRITTEN
Wednesday, April 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 11, 2023NON-FINAL ACTION E-MAILED
Wednesday, January 11, 2023NON-FINAL ACTION WRITTEN
Monday, January 9, 2023ASSIGNED TO EXAMINER
Tuesday, March 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2022NEW APPLICATION ENTERED